Max Healthcare Institute Limited (NSE:MAXHEALTH)
India flag India · Delayed Price · Currency is INR
927.15
+31.65 (3.53%)
Nov 4, 2026, 3:29 PM IST

Max Healthcare Institute Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
91,45883,73570,28554,06045,62639,366
91,45883,73570,28554,06045,62639,366
Revenue Growth
15.17%19.14%30.01%18.49%15.90%56.96%
Cost of Revenue
33,76831,47126,51120,52917,31417,481
Gross Profit
57,69052,26343,77433,53128,31221,885
Selling, General & Admin
20,02517,94014,74711,1699,8638,729
Other Operating Expenses
13,09211,86810,1577,1595,8873,365
Operating Expenses
38,15234,27428,49920,77818,07214,305
Operating Income
19,53817,99015,27512,75310,2407,580
Interest Expense
-2,511-2,150-1,488-445.6-713.2-900.1
Interest & Investment Income
1,3001,1501,1721,5621,124750.9
Currency Exchange Gain (Loss)
-26.6-26.6-73-2.4-3.4
Other Non Operating Income (Expenses)
184.5213.5204.441.686.7207.3
EBT Excluding Unusual Items
18,48417,17715,15813,91410,7357,634
Merger & Restructuring Charges
-143.4-143.4-736.3---90.3
Gain (Loss) on Sale of Assets
6.56.51.14.513.3-30.6
Asset Writedown
------0.6
Other Unusual Items
-283.8-283.8-358.8-265.4-111.2-123.8
Pretax Income
18,06416,75614,06413,65310,6377,389
Income Tax Expense
4,2582,3323,3053,077-397.91,339
Earnings From Continuing Operations
13,80614,42410,75910,57611,0356,051
Net Income to Company
13,80614,42410,75910,57611,0356,051
Minority Interest in Earnings
0.2-----
Net Income
13,80614,42410,75910,57611,0356,051
Net Income to Common
13,80614,42410,75910,57611,0356,051
Net Income Growth
1.73%34.07%1.73%-4.16%82.38%-
Shares Outstanding (Basic)
973972972972970967
Shares Outstanding (Diluted)
977977977975972969
Shares Change
-0.06%-0.00%0.20%0.39%0.24%12.30%
EPS (Basic)
14.1914.8311.0710.8911.386.25
EPS (Diluted)
14.1314.7611.0110.8411.366.24
EPS Growth
1.81%34.06%1.57%-4.58%82.05%-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
5,9581,4884,9353,3579,4851,872
Free Cash Flow Per Share
6.101.525.053.449.761.93
Dividend Per Share
-2.0001.5001.5001.000-
Dividend Growth
-33.33%0%50.00%--
Gross Margin
63.08%62.41%62.28%62.02%62.05%55.59%
Operating Margin
21.36%21.48%21.73%23.59%22.44%19.25%
Profit Margin
15.10%17.23%15.31%19.56%24.19%15.37%
Free Cash Flow Margin
6.51%1.78%7.02%6.21%20.79%4.75%
EBITDA
23,90621,78818,31214,81912,2269,465
EBITDA Margin
26.14%26.02%26.05%27.41%26.80%24.04%
D&A For EBITDA
4,3683,7983,0372,0661,9861,886
EBIT
19,53817,99015,27512,75310,2407,580
EBIT Margin
21.36%21.48%21.73%23.59%22.44%19.25%
Effective Tax Rate
23.57%13.92%23.50%22.54%-18.12%
Revenue as Reported
93,20485,36171,84155,83047,01840,588
Advertising Expenses
-----446.2